News coverage about Nutraceutical Int'l (NASDAQ:NUTR) has trended positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nutraceutical Int'l earned a media sentiment score of 0.28 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.9478071982607 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Shares of Nutraceutical Int'l (NASDAQ NUTR) traded up $0.05 during midday trading on Thursday, hitting $41.80. The stock had a trading volume of 193,800 shares, compared to its average volume of 62,847. Nutraceutical Int'l has a 1 year low of $24.92 and a 1 year high of $42.45. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.40 and a quick ratio of 1.42. The stock has a market cap of $386.52, a PE ratio of 26.97 and a beta of 0.48.
About Nutraceutical Int'l
Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company’s products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products.
Receive News & Ratings for Nutraceutical Int'l Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutraceutical Int'l and related companies with MarketBeat.com's FREE daily email newsletter.